Similar articles

• [Growth factors and the extracellular matrix].

  Saksela O, Laiho M. Saksela O, et al. Duodecim. 1990;106(3):297-306. Duodecim. 1990. PMID: 1670094 Review. Finnish. No abstract available.
• Compartmentalization of growth factor receptor signalling.

  Hoeller D, Volarevic S, Dikic I. Hoeller D, et al. Curr Opin Cell Biol. 2005 Apr;17(2):107-11. doi: 10.1016/j.ceb.2005.01.001. Curr Opin Cell Biol. 2005. PMID: 15780584 Review.
• Development and characterization of DP-153, a nontumorigenic prostatic cell line that undergoes malignant transformation by expression of dominant-negative transforming growth factor beta receptor type II.

  Song K, Cornelius SC, Danielpour D. Song K, et al. Cancer Res. 2003 Aug 1;63(15):4358-67. Cancer Res. 2003. PMID: 12907605
• [The role of alphavbeta3 integrin in changes of the invasive phenotype in CP-transformed fibroblasts with multiple drug resistance].

  Morozevich GE, Kozlova NI, Chubukina AN, Berman AE. Morozevich GE, et al. Vopr Med Khim. 2002 Jan-Feb;48(1):111-20. Vopr Med Khim. 2002. PMID: 12068493 Russian.
• Molecular aspects of adrenal tumours.

  McNicol AM. McNicol AM. Minerva Endocrinol. 1995 Mar;20(1):9-13. Minerva Endocrinol. 1995. PMID: 7651288 Review. No abstract available.